I am not a high-tech person. When I first turned on Spiro PD, I started using it. I hardly had to refer to the manual. I am delighted with it.
Allentown, Pennsylvania (PRWEB) August 28, 2012
PMD Healthcare recently launched Spiro PD, the world’s first truly personal spirometer. Since then, people with a variety of respiratory conditions have adopted Spiro PD and are talking about how it helps them better manage their respiratory condition.
As the world’s first truly personal spirometer, Spiro PD empowers people with lung diseases – cystic fibrosis (CF), asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, and lung transplants – to easily and accurately monitor their breathing any time and anywhere: at home, at work, at school, at play, or while traveling.
Gary Toulouse, a 64-year-old resident of Bay City, Michigan, received a double lung transplant in 2010. Since using Spiro PD, Gary says, “It has helped make me more active. When used correctly, Spiro PD provides accurate information that I then email to my transplant team and doctor. So it helps them see if there is any problem, and take whatever action is needed to correct it.”
Gary continues: “I test my lung function twice a day by blowing into Spiro PD. I’ve improved so much that I have once again picked up the clarinet. I’m playing almost as good as when I was young!”
MaryAnn Leonardo also has achieved similar results thanks to Spiro PD. MaryAnn was diagnosed with asthma in 1994. “Before Spiro PD,” says MaryAnn, “I was more passive about my asthma. But Spiro PD has empowered me to take a more active role in managing my condition. Spiro PD lets me see trends in my lung function and reminds me to take my medications on schedule.”
MaryAnn also commented on Spiro PD’s ease of use: “I am not a high-tech person. When I first turned on Spiro PD, I started using it. I hardly had to refer to the manual. I am delighted with it.”
Says Wayne Meng, Founder, Chief Executive Officer, and President of PMD Healthcare, “My daughter has sport-induced asthma. That is one of the reasons we developed Spiro PD. Our goal was to help improve the lives of people with respiratory conditions. And it is so fulfilling to hear patients say that Spiro PD does just that.”
For more information about all the advantages that Spiro PD offers people with respiratory conditions, please visit http://www.SpiroPD.com.
About Spiro PD
“Spiro" stands for spirometer, a device used to measure air entering and leaving the lungs; "PD" stands for personal device. Spiro PD is the first personal spirometer that enables people with lung diseases – asthma, COPD, CF, and lung transplants – to easily and accurately monitor their breathing anytime and anywhere.
Spiro PD tracks lung function trends to help patients anticipate and prevent exacerbations and asthma attacks, which helps reduce expensive emergency room visits and hospital stays. According to a recent study of cystic fibrosis patients at Johns Hopkins, home spirometry detected exacerbations 16 days before patients felt symptoms and sought medical care.(1)
Spiro PD enhances medication adherence. The medication alarm helps patients remember to take their medicine. The medication history provides a time stamp to show doctors that patients have been following their therapy.
Spiro PD also allows patients to set alarms reminding them to perform spirometry tests and do breathing exercises. Plus, patients can quickly upload data to their computer and share it with their doctor.
Spiro PD is cleared by the FDA for home use by the patient to test lung function in children, adolescents, and adults. Spiro PD is certified with the CE mark for the European Union (EU). Spiro PD also meets American Thoracic Society (ATS) and European Respiratory Society (ERS) standards.
For more information visit http://www.SpiroPD.com.
About PMD Healthcare, Inc.
PMD Healthcare, manufacturer of Spiro PD, is dedicated to creating innovative, easy-to-use, portable, and affordable personal medical devices that empower people worldwide to improve their healthcare and quality of life. For more information about PMD Healthcare and Spiro PD, please visit http://www.SpiroPD.com.
1. West NE, Boyle MP, Mogayzel PJ, Riekert KA, Lechtzin N. The ability of home spirometry and symptom monitoring to predict exacerbations in cystic fibrosis. Pediatric Pulmonology 2009; Vol. 34, S32 “Poster Session Abstract” poster 376.